Theodora Kanni

1.8k total citations
22 papers, 671 citations indexed

About

Theodora Kanni is a scholar working on Dermatology, Surgery and Epidemiology. According to data from OpenAlex, Theodora Kanni has authored 22 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Dermatology, 13 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Theodora Kanni's work include Hidradenitis Suppurativa and Treatments (14 papers), Colorectal and Anal Carcinomas (12 papers) and Microscopic Colitis (7 papers). Theodora Kanni is often cited by papers focused on Hidradenitis Suppurativa and Treatments (14 papers), Colorectal and Anal Carcinomas (12 papers) and Microscopic Colitis (7 papers). Theodora Kanni collaborates with scholars based in Greece, Germany and United States. Theodora Kanni's co-authors include Evangelos J. Giamarellos‐Bourboulis, Charles A. Dinarello, Vassiliki Tzanetakou, Alexander Katoulis, Evangelia Papadavid, Mihai G. Netea, S. Giatrakou, Athina Savva, Dimitrios Rigopoulos and J.W.M. van der Meer and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Investigative Dermatology.

In The Last Decade

Theodora Kanni

21 papers receiving 665 citations

Peers

Theodora Kanni
Klaus Vander Austria
Lotte Boxhoorn Netherlands
Dawn Cooper United States
Priya Patel United States
L Feldmann France
Dawn E. Sailer United States
Reto Kurmann United States
J. S. Cheigh United States
Kristine E. Konopka United States
Klaus Vander Austria
Theodora Kanni
Citations per year, relative to Theodora Kanni Theodora Kanni (= 1×) peers Klaus Vander

Countries citing papers authored by Theodora Kanni

Since Specialization
Citations

This map shows the geographic impact of Theodora Kanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodora Kanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodora Kanni more than expected).

Fields of papers citing papers by Theodora Kanni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodora Kanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodora Kanni. The network helps show where Theodora Kanni may publish in the future.

Co-authorship network of co-authors of Theodora Kanni

This figure shows the co-authorship network connecting the top 25 collaborators of Theodora Kanni. A scholar is included among the top collaborators of Theodora Kanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodora Kanni. Theodora Kanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanni, Theodora, Sofia Ira Ktena, Konstantinos Leventogiannis, et al.. (2025). Prevalence of Hidradenitis Suppurativa in Athens, Greece: A Cross-Sectional Study Based on a Validated Questionnaire. Dermatology. 241(Suppl. 1). 52–56.
2.
Kanni, Theodora, et al.. (2024). An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa. Expert Opinion on Biological Therapy. 24(4). 225–232. 6 indexed citations
3.
Leventogiannis, Konstantinos, Antigone Kotsaki, Theodora Kanni, et al.. (2023). Evaluation of the Novel Sepsis Biomarker Host-Derived Delta-like Canonical Notch Ligand 1—A Secondary Analysis of 405 Patients Suffering from Inflammatory or Infectious Diseases. International Journal of Molecular Sciences. 24(11). 9164–9164. 2 indexed citations
4.
Trigoni, Anastasia, Jessica Kaffenberger, Georgia Damoraki, et al.. (2023). Impact of Single Nucleotide Polymorphisms of the Promoter of the TNF Gene on Adalimumab Treatment Responses in Hidradenitis Suppurativa. Dermatology. 239(5). 746–752. 2 indexed citations
5.
Tzanetakou, Vassiliki, et al.. (2023). Immune Classification of Hidradenitis Suppurativa: Modulation by Secukinumab. Journal of Investigative Dermatology. 143(12). 2518–2520.e3. 3 indexed citations
6.
Tzanetakou, Vassiliki, et al.. (2021). <b><i>Staphylococcus aureus</i></b> Carriage in Hidradenitis Suppurativa: Impact on Response to Adalimumab. Dermatology. 237(3). 372–377. 4 indexed citations
7.
Michalopoulos, Giorgos D., et al.. (2020). Rosacea and Helicobacter pylori, is there any Relationship?. 3(2). 1 indexed citations
8.
Kanni, Theodora, et al.. (2020). Development of New Lesions of Hidradenitis Suppurativa on a Caesarean Section Scar: A Manifestation of the Koebner Phenomenon?. Skin Appendage Disorders. 6(3). 155–157. 6 indexed citations
9.
Kanni, Theodora, et al.. (2018). Cryoanalgesia with a CoolSense Device in Patients Treated with Botulinum Toxin-A for Palmar-Plantar Hyperhidrosis: A Self-Controlled Study. Skin Appendage Disorders. 5(2). 119–120. 4 indexed citations
10.
Kanni, Theodora, et al.. (2018). Cost‐savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real‐world cohort. British Journal of Dermatology. 180(5). 1161–1168. 14 indexed citations
11.
Kanni, Theodora, Themistoklis Spyridopoulos, Aikaterini Pistiki, et al.. (2017). MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study. Journal of Investigative Dermatology. 138(4). 795–801. 83 indexed citations
12.
Giamarellos‐Bourboulis, Evangelos J., Matthias Platzer, Ioannis Karagiannidis, et al.. (2016). High Copy Numbers of β-Defensin Cluster on 8p23.1, Confer Genetic Susceptibility, and Modulate the Physical Course of Hidradenitis Suppurativa/Acne Inversa. Journal of Investigative Dermatology. 136(8). 1592–1598. 39 indexed citations
13.
Kanni, Theodora, Vassiliki Tzanetakou, Athina Savva, et al.. (2015). Compartmentalized Cytokine Responses in Hidradenitis Suppurativa. PLoS ONE. 10(6). e0130522–e0130522. 52 indexed citations
14.
Tzanetakou, Vassiliki, Theodora Kanni, S. Giatrakou, et al.. (2015). Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa. JAMA Dermatology. 152(1). 52–52. 191 indexed citations
15.
Giamarellos‐Bourboulis, Evangelos J., Aikaterini Spyridaki, Athina Savva, et al.. (2014). Intravenous Paracetamol as an Antipyretic and Analgesic Medication: the Significance of Drug Metabolism. Journal of Pharmacological Sciences. 124(2). 144–152. 8 indexed citations
16.
Huse, Klaus, Theodora Kanni, Vassiliki Tzanetakou, et al.. (2013). Haplotypes of IL-12Rβ1 impact on the clinical phenotype of hidradenitis suppurativa. Cytokine. 62(2). 297–301. 26 indexed citations
17.
Giamarellos‐Bourboulis, Evangelos J., Efterpi Apostolidou, Malvina Lada, et al.. (2013). Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome. Critical Care. 17(5). R247–R247. 56 indexed citations
18.
Savva, Athina, Theodora Kanni, Georgia Damoraki, et al.. (2012). Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa. British Journal of Dermatology. 168(2). 311–317. 40 indexed citations
19.
Douzinas, Emmanuel E., Alex P. Betrosian, Olga Livaditi, et al.. (2009). Hypoxemic resuscitation after hemorrhagic shock is accompanied by reduced serum levels of angiopoietin-2. Cytokine. 47(2). 82–84. 5 indexed citations
20.
Antonopoulou, Anastasia, Maria Raftogiannis, Fotini Baziaka, et al.. (2009). Effect of the novel influenza A (H1N1) virus in the human immune system. Critical Care. 13(Suppl 4). P24–P24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026